Skyhawk Therapeutics, Inc.
Clinical trials sponsored by Skyhawk Therapeutics, Inc., explained in plain language.
-
Hope for Huntington's: new pill aims to tame toxic proteins
Disease control ENROLLING_BY_INVITATIONThis study tests an oral drug called SKY-0515 in 500 adults with Huntington's disease who have already taken it before. The goal is to see if the drug can safely lower harmful proteins and improve symptoms over the long term. Participants must be 25 or older and have a genetic co…
Phase: PHASE2, PHASE3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
New pill aims to tackle Huntington's at its source
Disease control OngoingThis study tests an oral drug called SKY-0515 in 120 adults with Huntington's disease. The goal is to see if it can lower a harmful protein linked to the disease and improve symptoms. Participants take the drug or a placebo for a set period, and researchers monitor changes in pro…
Phase: PHASE2, PHASE3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated May 18, 2026 12:00 UTC